Martin J Gepsman sold $89k of CME
director at CME GROUP INC.. 400 shares at an average of $222.92, traded Nov 4, 2024, filed Nov 4, 2024.
Score components
- +15RoleDirector
- +9Trade size$89k at market
- 0Share of holdings soldSold 1.6% of holdings
- +15Cluster5 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +8.9%, 3m +11.1%, 6m +31.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001156375-24-000196, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 4, 2024 | SOpen-market sale Common Stock Class A | -400 | $222.92 | $89k | 25,067 | Nov 4, 2024 |
Related signals
Other insiders at CME GROUP INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 19Weak | CMEbuy CME GROUP INC. | William R Shepard director | $79k 293 shares | +0% | |
| 34Weak | CME GROUP INC. | Elizabeth A Cook director | $140k 500 shares | -3% | |
| 68Notable | CME GROUP INC. | Terrence A Duffy Chairman and CEO | $4.1M 15,000 shares | -27% | |
| 18Weak | CMEbuy CME GROUP INC. | William R Shepard director | $72k 267 shares | +0% | |
| 26Weak | CMEsell CME GROUP INC. | Charles P Carey director | $133k 500 shares | -9% | |
| 46Moderate | CME GROUP INC. | Daniel G Kaye director | $141k 500 shares | -12% | |
| 20Weak | CME GROUP INC. | Jonathan L Marcus Sr MD General Counsel | $108k 390 shares | -5% | |
| 54Moderate | CME GROUP INC. | Phyllis M Lockett director | $295k 1,060 shares | -25% | |
| 62Notable | CME GROUP INC. | Charles P Carey director | $818k 3,000 shares | -36% | |
| 39Weak | CME GROUP INC. | Martin J Gepsman director | $82k 300 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.